Years of extensive testing must be performed on any potential new treatment prior to being approved for use in the clinical to treat patients. The Privette Vinnedge laboratory conducts pre-clinical studies of new breast cancer treatments to determine their efficacy and feasibility for future use in clinical trials. We collaborate with Nicolas Nassar
, JooYoup Lee
, and other investigators to test nanoparticles and small molecules as potential new breast cancer therapies.